Chad W. Souvignier
InvestorVice President at Research Corporation Technologies · Board director at seqWell
Tucson
Find your path to Chad
15 people in our graph share verified history with Chad — schools, employers, funds. One of them is your warm intro.
About
Souvignier performs scientific and business analysis of early-stage biomedical investment opportunities and manages a portfolio of RCT projects and investments, focusing on life science tools and therapeutics. He has held roles at RCT since 2003, previously worked at Guilford Pharmaceuticals, and holds a Ph.D. in Materials Science and an MBA from the University of Arizona.
Contact· self-published, not guessed
Invests in
BiotechHealthtechMedical Devices
Board director at seqWell
Intro paths
In turn, Chad can intro founders to seqWell's investors below.
seqWell's investors · 1
Investments
Board seats
Biolog, Inc.Calosyn Pharmaceuticals Inc.Esperance Pharmaceuticals, Inc.Halo Labs, Inc.Jenrin Discovery Inc.Seqwell, IncTD2
Per the firm's website.
Colleagues at Research Corporation Technologies
Frequently asked questions
- Who is Chad W. Souvignier?
- Souvignier performs scientific and business analysis of early-stage biomedical investment opportunities and manages a portfolio of RCT projects and investments, focusing on life science tools and therapeutics. He has held roles at RCT since 2003, previously worked at Guilford Pharmaceuticals, and holds a Ph.D. in Materials Science and an MBA from the University of Arizona.
- Where does Chad W. Souvignier work?
- Chad W. Souvignier is Vice President at Research Corporation Technologies and Board director at seqWell.
- What does Chad W. Souvignier invest in?
- Chad W. Souvignier invests in Biotech, Healthtech, Medical Devices.
- What boards does Chad W. Souvignier sit on?
- Chad W. Souvignier holds tracked board seats at Biolog, Inc., Calosyn Pharmaceuticals Inc., Esperance Pharmaceuticals, Inc., Halo Labs, Inc., Jenrin Discovery Inc., Seqwell, Inc, TD2.